Articles tagged with Bacterial Infections
Researchers identified components of the C. difficile bacteria that can be used to develop a rapid diagnostic test, potentially leading to more timely initiation of antibiotics and improved outcomes for patients. The study's technology can also help quickly detect and identify hypervirulent strains of the bacterium.
Researchers at VIB have identified a chemical substance that can disarm pathogenic bacteria, allowing them to treat urinary tract infections without destroying beneficial bacteria. This approach could provide a lower risk of resistance development and spread.
Scientists are conducting a Phase 1 clinical trial of EDP-788, an oral antibiotic targeting methicillin-resistant Staphylococcus aureus (MRSA) infections. The trial will evaluate the safety and pharmacokinetics of the drug in healthy participants.
Researchers at SISSA investigated the structural elements of prion proteins, finding that misfolding originates in the N-terminal region. This knowledge is crucial for developing drugs and therapeutic strategies against diseases like Creutzfeldt-Jakob disease.
A study published in Infection and Immunity reveals that Salmonella infection can reduce asthma inflammation by regulating immune cells. Researchers hope to develop treatments based on probiotics or therapeutic applications of myeloid cells.
Researchers found that females who mated with preferred males produced more offspring and were better able to cope with infection from Salmonella compared to offspring sired by non-preferred males. The fitness benefits were due to tolerance to infection rather than immune resistance.
Scientists will analyze 510 archived isolates of Campylobacter from human faeces to better understand its sources and transmission routes. The study aims to prevent Campylobacter-related illnesses, which cause over 21,000 hospital admissions and 100 deaths in the UK each year.
Research found significantly higher levels of infectious pathogens in water from faucet taps with aerators compared to deeper in the plumbing system. Contaminated water threatens immunocompromised patients with increased infection risk.
Researchers discovered how Group A streptococcus turns deadly and found a potential new treatment using asparaginase, a protein that digests asparagine. This study opens the way to possible new treatments for bacterial infections.
Two small RNAs (sRNAs) GlmY and GlmZ orchestrate bacterial attack on epithelial cells by cleaving transcripts and destabilizing LEE gene expression. This coordination enables efficient mammalian-cell invasion and optimal pedestal formation.
A new study found that the human body louse can transmit bacterial infections to humans, while the human head louse does not. The researchers discovered that several immune genes were regulated differently in head and body lice after infection with the bacteria, and the infection progressed further in body lice over time.
A new study found that acute otitis media, or ear infection, is associated with significant increases in direct costs incurred by consumers and the health care system. The research showed that pediatric AOM accounts for approximately $2.88 billion in added health care expenses annually.
Researchers from the University of Copenhagen have identified marine bacteria that can effectively inhibit the ability of staphylococci to form toxins and camouflage proteins. These compounds, known as antivirulence therapy, may offer a new solution for treating resistant bacterial infections.
A special focus issue on sepsis investigates the complex interplay between pathogens and host defense mechanisms that contribute to septic shock. Key findings highlight the importance of early recognition and improved therapies for managing multi-organ dysfunction.
A study published in the American Journal of Infection Control found a significant decrease in MRSA infections in Veterans Affairs long-term care facilities over a 42-month period. The MRSA Prevention Initiative, which included screening, hand hygiene, and institutional culture change, led to a 36% overall decline in MRSA infections.
A study published in Infection and Immunity found that Streptococcus pneumoniae and Streptococcus pyogenes bacteria persist on surfaces for far longer than previously thought, posing a risk of infection to individuals in settings like schools and healthcare facilities.
The agriculture and aquaculture industries' overuse of antibiotics is creating a global health crisis by promoting antibiotic-resistant bacteria. A new proposal suggests implementing user fees to reduce non-human use of antibiotics, encouraging more efficient farming practices.
A new study found that nearly one in four healthcare workers' hands were contaminated with C. difficile spores after routine care of patients infected with the bacteria. Effective hand hygiene is crucial to prevent the spread of this highly contagious bacteria.
A Kaiser Permanente study found that hospital-diagnosed maternal bacterial infections during pregnancy were associated with an increased risk of autism spectrum disorders in children. The study included 407 children with autism and 2,075 matched children who did not have autism.
Researchers at the University of Iowa have developed a new vaccine that targets staph toxins, providing almost complete protection against staph infections. The vaccine was tested in an animal model and found to be effective even against high doses of bacteria.
TB-causing bacteria mask their molecular patterns using cell surface lipids, evading immune detection. The presence of lipid molecule PGL promotes the recruitment of permissive macrophages that allow TB to establish an infection in deeper lung tissue.
Campylobacter infection affects millions more than Salmonella, with antibiotic resistance a growing concern. Researchers seek to understand biofilm formation and regulate CsrA's role in making the sugar coating that enables bacterial survival.
Researchers developed a coating that reduces stress and bacterial adhesion, minimizing the risk of infection. The new coating combines hydroxyapatite and beta-tricalcium phosphate, improving cell proliferation and implant integration.
A single strain of Escherichia coli, known as H30-Rx, has become the main cause of bacterial infections worldwide, spreading from urinary tract to blood and causing lethal sepsis. The study's findings suggest that this superbug may be responsible for 1.5 million UTIs and tens of thousands of deaths annually in the US.
The MRSA USA300 strain acquired genes from skin bacteria, allowing it to thrive on human skin where other strains cannot. This adaptation enabled the strain to dominate and spread rapidly across the US, becoming the leading cause of community-acquired MRSA infections.
Researchers have identified diverse strains of Wolbachia bacteria that offer strong antiviral protection against diseases like dengue, but may come with a cost to the host's lifespan. The study found that certain strains replicate more quickly and reach higher concentrations in flies, potentially reducing their lifespan.
Researchers discovered a temporary tube-shaped structure in the phiX174 virus to deliver its DNA during infection. The tube attaches to host cell membranes and contains amino acids ideal for DNA transfer. This finding may be crucial for efficient genome translocation.
A new animal study led by researchers at the University of Pittsburgh School of Medicine found that TB lung lesions are surprisingly variable and independent of each other, regardless of whether the patient has clinically active or latent disease. The findings could point the way to new vaccines to prevent the hard-to-treat infection.
Researchers at UTMB have discovered a way to block disease pathways that could defeat devastating human infections. A new candidate drug inhibiting Epac has been shown to protect normal mice from fatal rickettsial infection and may also be effective against some viral infections.
Researchers at Kansas State University are exploring how E. coli proteins block the host's innate immune system, which is critical for infection prevention. Understanding this mechanism may lead to new therapeutics for autoimmune diseases and cancer.
Researchers have identified phosphatases in human cells that are involved in bacterial survival and found small molecules that can stop them from working. This approach jams the host cell machinery rather than directly attacking the bacteria, potentially reducing the risk of resistance development.
Scientists have resolved the 'chlamydial anomaly' by detecting peptidoglycan in Chlamydia trachomatis. The novel method used reveals regions where the molecule is produced, confirming its presence.
Researchers found that gut microbiota influences MicroRNA expression in mice infected with Listeria monocytogenes. Conventional mice exhibited lower miRNA levels after infection compared to germ-free mice, suggesting a protective role for the gut microbiome.
Researchers at the Helmholtz Centre for Infection Research found that mice lacking Tmprss2 protein are protected against certain flu viruses, including H1N1. This discovery highlights a potential new approach to treating flu infections by targeting the host's metabolism.
Scientists at the University of Maryland have developed a novel RNA-Seq analysis method that reveals the complex interplay between invading bacterial pathogens and their host mammalian cells. The study found that human immune responses to chlamydial infection contribute to disease, leading to tissue scarring.
A new technique uses whole genome sequencing to identify pathogens in patient samples in just 18 hours, allowing for rapid diagnosis and treatment of urinary tract infections. This approach also enables the detection of emerging infections and prevention of hospital-acquired diseases.
Tel Aviv University researchers have discovered a protein that kills bacteria, potentially offering a new antibiotic substitute. The protein, produced by a virus that attacks bacteria, impedes cell division in E. coli and causes cells to elongate and die.
A nanosponge vaccine has been developed to combat MRSA toxins, triggering neutralizing antibodies and fighting off lethal doses in mice. The vaccine was found to be safer and more effective than traditional toxoid vaccines made from heat-treated staph toxin.
Restoring the normal, helpful bacteria of the gut and intestines may treat patients suffering from recurrent C. difficile infections through fecal matter transplantation. The study found that transplanting fecal matter into patients with RCDI restores normal bacterial composition and resolves infection.
Researchers are using experimental hydrodynamics to track the source of lethal outbreaks in Great Lakes waterfowl. They have developed a novel way of tracking waterfowl carcasses and performed towing tank experiments to determine drag coefficients, which will help identify locations where waterbirds are likely exposed to botulinum toxin.
A recent study published in PLOS Pathogens has shed light on why some ear and respiratory infections become chronic. Researchers discovered that the bacterium nontypeable Haemophilus influenzae uses its host's immune response to its advantage, allowing it to evade detection and thrive.
Researchers from Helmholtz Centre for Infection Research have discovered a new dual-RNA guided enzyme Cas9 that enhances the potential of exploiting bacterial immune systems for genome engineering. The CRISPR-Cas system has been shown to be faster, more precise and cheaper than existing technologies.
The University of Chicago researchers will investigate 102 hypothetical genes from plague and brucellosis bacteria using cross-disciplinary approaches. This research aims to assign functions to these genes, which could inform studies across species with similar genes.
Researchers discovered that S. aureus converts neutrophil extracellular traps into a toxic molecule, dAdo, which kills macrophages and allows the bacteria to avoid immune destruction. The study provides new insights into the mechanisms behind S. aureus infections and offers potential therapeutic targets.
A special issue of Gut Microbes explores the role of H. pylori in stomach cancer, as well as its impact on the natural stomach ecology and relationship with hepatitis C virus-associated liver cancer. The studies discuss various factors contributing to H. pylori-induced gastric cancer.
The report highlights the growing problem of antibiotic resistance, its major causes and consequences, and identifies key areas in which action is urgently needed. The authors call for a fundamental shift in how antibiotics are developed, financed, and prescribed to address this threat.
Northeastern researchers have developed a new treatment to cure MRSA infections by targeting dormant cells called persisters. The approach uses a drug called ADEP, which effectively wakes up and eliminates these expert survivors, leading to complete eradication of the bacterial population.
Researchers at San Francisco State University use mathematical analysis to model the separation of bacterial chromosomes, revealing a stepwise process. This study could lead to the design of better antibacterial drugs and a deeper understanding of DNA topology.
A new method developed in collaboration with Unisensor A/S can determine the optimal antibiotic treatment for a given bacterial infection within 2-4 hours, reducing the response time by half. This faster diagnosis can help prevent the development of resistant bacteria and shorten disease courses.
A new clinical score test for patients with sore throats can reduce antibiotic use by almost 30% and improve symptoms more quickly. The FeverPAIN score considers fever, pus infection, rapid attendance, inflamed tonsils, and cough or cold symptoms to determine if antibiotics are needed.
Scientists have discovered a molecule called CNFy produced by the bacteria Yersinia pseudotuberculosis, which facilitates the infection process by manipulating the host cells' molecular switches. This allows the bacteria to inject toxins into immune cells more efficiently, leading to inflammation and tissue damage.
Researchers found strong divergences in mtDNA, suggesting cryptic speciation, but no differences in nuclear DNA markers. Wolbachia infections can mimic this phenomenon, leading to false results in DNA barcoding studies. The study warns against relying solely on DNA barcoding for species identification.
Research at Cincinnati Children's Hospital Medical Center reveals that newborn infants' immune systems suppress helpful bacteria colonization by CD71+ cells, leading to infection susceptibility. The study proposes a new explanation for neonatal infections and suggests temporary immune suppression extends beyond the intestines.
Scientists have identified Lactobacillus brevis from a traditional Japanese pickle as having protective effects against influenza virus infection in mice. The bacteria's unique properties, including exopolysaccharides, are thought to enhance immune system function and eradicate virus-infected cells.
A three-year project aims to create an oral vaccine against C. difficile, which kills thousands annually. The novel approach uses harmless bacterial spores to boost immunity and targets the protein needed for the infection to take hold.
Scientists from the University of Sheffield have partnered with an Indian team to develop a new technology that can rapidly diagnose and treat corneal infections, potentially saving thousands of patients' eyesight. The technology uses polymers that trap bacteria or fungi in place, allowing for easy removal.
A new study found that a patient's immune response may provide better insights into bacterial infections than conventional tests, leading to more accurate diagnoses and appropriate antibiotic treatment. The research identified unique 'immune fingerprints' associated with certain pathogens and predicted the nature of the infection.
Researchers from the University of Missouri School of Medicine found a more accurate way to screen for bacterial meningococcal infection in its early stages. They discovered that abnormalities in neutrophil counts can indicate a serious infection, including meningococcal disease.
After implementing a national initiative to reduce MRSA rates, cases have continued to decline in VA medical centers. The initiative resulted in significant decreases in both transmission and healthcare-associated infection rates, with notable declines in non-ICU settings.
A new €6 million global research program, CF Matters, aims to develop personalized antibiotic treatments for Cystic Fibrosis patients. The study will use molecular next-generation DNA sequencing methods to detect bacteria present in patients' sputum and determine the most effective antibiotic treatment.